Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I

PHASE3CompletedINTERVENTIONAL
Enrollment

1,071

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Asthma
Interventions
DRUG

Placebo

Placebo that represents comparator

DRUG

tiotropium Respimat® low dose

IMP

DRUG

Placebo

Placebo that represents comparator

DRUG

Placebo

Placebo that represents comparator

DRUG

tiotropium Respimat® high dose

IMP

DRUG

50 mcg salmeterol HFA MDI

Active comparator

DRUG

Placebo

Placebo that represents BI drug

DRUG

Placebo

Placebo that represents BI drug

Trial Locations (114)

Unknown

205.418.01020 Boehringer Ingelheim Investigational Site, Huntington Beach

205.418.01002 Boehringer Ingelheim Investigational Site, Mission Viejo

205.418.01014 Boehringer Ingelheim Investigational Site, San Diego

205.418.01011 Boehringer Ingelheim Investigational Site, Wheat Ridge

205.418.01004 Boehringer Ingelheim Investigational Site, Coeur d'Alene

205.418.01017 Boehringer Ingelheim Investigational Site, Normal

205.418.01008 Boehringer Ingelheim Investigational Site, South Bend

205.418.01012 Boehringer Ingelheim Investigational Site, Baltimore

205.418.01013 Boehringer Ingelheim Investigational Site, North Dartmouth

205.418.01015 Boehringer Ingelheim Investigational Site, North Dartmouth

205.418.01009 Boehringer Ingelheim Investigational Site, Minneapolis

205.418.01006 Boehringer Ingelheim Investigational Site, Bellevue

205.418.01016 Boehringer Ingelheim Investigational Site, Boys Town

205.418.01003 Boehringer Ingelheim Investigational Site, Omaha

205.418.01021 Boehringer Ingelheim Investigational Site, Winston-Salem

205.418.01018 Boehringer Ingelheim Investigational Site, Oklahoma City

205.418.01005 Boehringer Ingelheim Investigational Site, Charleston

205.418.01010 Boehringer Ingelheim Investigational Site, Easely

205.418.01007 Boehringer Ingelheim Investigational Site, Dallas

205.418.01019 Boehringer Ingelheim Investigational Site, Seattle

205.418.01001 Boehringer Ingelheim Investigational Site, Tacoma

205.418.55002 Boehringer Ingelheim Investigational Site, Juiz de Fora

205.418.55001 Boehringer Ingelheim Investigational Site, Porto Alegre

205.418.55004 Boehringer Ingelheim Investigational Site, Porto Alegre

205.418.55005 Boehringer Ingelheim Investigational Site, Porto Alegre

205.418.55003 Boehringer Ingelheim Investigational Site, Rio de Janeiro - RJ

205.418.86001 Boehringer Ingelheim Investigational Site, Beijing

205.418.86005 Boehringer Ingelheim Investigational Site, Beijing

205.418.86007 Boehringer Ingelheim Investigational Site, Beijing

205.418.86012 Boehringer Ingelheim Investigational Site, Beijing

205.418.86014 Boehringer Ingelheim Investigational Site, Changsha

205.418.86011 Boehringer Ingelheim Investigational Site, Chengdu

205.418.86015 Boehringer Ingelheim Investigational Site, Chengdu

205.418.86003 Boehringer Ingelheim Investigational Site, Chongqing

205.418.86010 Boehringer Ingelheim Investigational Site, Guangzhou

205.418.86013 Boehringer Ingelheim Investigational Site, Kunming

205.418.86008 Boehringer Ingelheim Investigational Site, Qingdao

205.418.86002 Boehringer Ingelheim Investigational Site, Shanghai

205.418.86004 Boehringer Ingelheim Investigational Site, Shenyang

205.418.86009 Boehringer Ingelheim Investigational Site, Shenyang

205.418.86006 Boehringer Ingelheim Investigational Site, Xi'an

205.418.50203 Boehringer Ingelheim Investigational Site, Guatelama City

205.418.50204 Boehringer Ingelheim Investigational Site, Guatelmala City

205.418.50205 Boehringer Ingelheim Investigational Site, Guatelmala City

205.418.50201 Boehringer Ingelheim Investigational Site, Guatemala City

205.418.50202 Boehringer Ingelheim Investigational Site, Guatemala City

205.418.91008 Boehringer Ingelheim Investigational Site, Banglore

205.418.91005 Boehringer Ingelheim Investigational Site, Chennai

205.418.91004 Boehringer Ingelheim Investigational Site, Coimbatore

205.418.91006 Boehringer Ingelheim Investigational Site, Coimbatore

205.418.91003 Boehringer Ingelheim Investigational Site, Hyderabad

205.418.91009 Boehringer Ingelheim Investigational Site, Jaipur

205.418.91002 Boehringer Ingelheim Investigational Site, Nagpur

205.418.91007 Boehringer Ingelheim Investigational Site, Pune

205.418.91010 Boehringer Ingelheim Investigational Site, Pune

205.418.81018 Boehringer Ingelheim Investigational Site, Adachi-ku, Tokyo

205.418.81030 Boehringer Ingelheim Investigational Site, Ako, Hyogo

205.418.81001 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo

205.418.81005 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

205.418.81025 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

205.418.81015 Boehringer Ingelheim Investigational Site, Fujioka, Gunma

205.418.81023 Boehringer Ingelheim Investigational Site, Himeji, Hyogo

205.418.81007 Boehringer Ingelheim Investigational Site, Hitachi, Ibaraki

205.418.81009 Boehringer Ingelheim Investigational Site, Iwamizawa, Hokkaido

205.418.81028 Boehringer Ingelheim Investigational Site, Kanazawa, Ishikawa

205.418.81011 Boehringer Ingelheim Investigational Site, Kitakami, Iwate

205.418.81012 Boehringer Ingelheim Investigational Site, Kitakami, Iwate

205.418.81031 Boehringer Ingelheim Investigational Site, Koga, Ibaraki

205.418.81016 Boehringer Ingelheim Investigational Site, Koganei, Tokyo

205.418.81006 Boehringer Ingelheim Investigational Site, Komaki, Aichi

205.418.81002 Boehringer Ingelheim Investigational Site, Kunitachi, Tokyo

205.418.81004 Boehringer Ingelheim Investigational Site, Mito, Ibaraki

205.418.81032 Boehringer Ingelheim Investigational Site, Osaka, Osaka

205.418.81019 Boehringer Ingelheim Investigational Site, Ota-ku, Tokyo

205.418.81008 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

205.418.81013 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

205.418.81014 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

205.418.81026 Boehringer Ingelheim Investigational Site, Setagaya-ku, Tokyo

205.418.81024 Boehringer Ingelheim Investigational Site, Takasaki, Gunma

205.418.81010 Boehringer Ingelheim Investigational Site, Tomakomai, Hokkaido

205.418.81003 Boehringer Ingelheim Investigational Site, Toshima-ku, Tokyo

205.418.81017 Boehringer Ingelheim Investigational Site, Toshima-ku, Tokyo

205.418.81022 Boehringer Ingelheim Investigational Site, Yao, Osaka

205.418.81020 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

205.418.81021 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

205.418.37004 Boehringer Ingelheim Investigational Site, Daugavpils

205.418.37008 Boehringer Ingelheim Investigational Site, Preiļi

205.418.37001 Boehringer Ingelheim Investigational Site, Riga

205.418.37002 Boehringer Ingelheim Investigational Site, Riga

205.418.37005 Boehringer Ingelheim Investigational Site, Riga

205.418.37006 Boehringer Ingelheim Investigational Site, Riga

205.418.37007 Boehringer Ingelheim Investigational Site, Riga

205.418.37009 Boehringer Ingelheim Investigational Site, Riga

205.418.37003 Boehringer Ingelheim Investigational Site, Ventspils

205.418.52002 Boehringer Ingelheim Investigational Site, Monterrey

205.418.52003 Boehringer Ingelheim Investigational Site, Zapopan

205.418.52001 Boehringer Ingelheim Investigational Site, Zona Río

205.418.51003 Boehringer Ingelheim Investigational Site, Callao

205.418.51001 Boehringer Ingelheim Investigational Site, Lima

205.418.51002 Boehringer Ingelheim Investigational Site, Lima

205.418.48006 Boehringer Ingelheim Investigational Site, Krakow

205.418.48001 Boehringer Ingelheim Investigational Site, Lodz

205.418.48005 Boehringer Ingelheim Investigational Site, Lodz

205.418.48002 Boehringer Ingelheim Investigational Site, Ostrow Wielkopolska

205.418.48004 Boehringer Ingelheim Investigational Site, Poznan

205.418.48003 Boehringer Ingelheim Investigational Site, Tczew

205.418.07007 Boehringer Ingelheim Investigational Site, Gatchina (Leningradskaya Oblast)

205.418.07004 Boehringer Ingelheim Investigational Site, Moscow

205.418.07005 Boehringer Ingelheim Investigational Site, Moscow

205.418.07006 Boehringer Ingelheim Investigational Site, Moscow

205.418.07008 Boehringer Ingelheim Investigational Site, Moscow

205.418.07001 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.418.07002 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.418.07003 Boehringer Ingelheim Investigational Site, Saint Petersburg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY